Mandeep Kaur, PhD

Senior Associate

Dr. Mandeep Kaur represents leading biotechnology and pharmaceutical companies in Intellectual Property matters with a focus on patent portfolio management, patent prosecution, and intellectual property due diligence. Mandeep leverages her extensive scientific experience in immuno-oncology, personalized medicine, and an interest in product commercialization in working with clients to manage their IP portfolios. Mandeep also works with Choate’s IP Litigation Group on patent infringement cases and post-grant proceedings.

Mandeep’s postdoctoral research at MIT focused on the development of humanized mice and neo-antigen CAR-T therapy for AML. Her doctoral thesis related to understanding molecular mechanisms of transcriptional repression by the oncogene c-Myc.  While at MIT, Mandeep was a Koch Institute Quinquennial Fellow and an IMPACT Fellow.

Publications and Presentations

  • “Induction and Therapeutic Targeting of Human NPM1c+ Myeloid Leukemia in the Presence of Autologous Immune System in Mice,” first author, Journal of Immunology, 2019.
  • “Commensal microflora-induced T cell responses mediate progressive neurodegeneration in glaucoma,” co-author, Nature Communications, 2018.
  • “Information-dense analysis for information-dense understanding,” co-first author, Translational Cancer Research, 2016.
  • “Interleukins 7 and 15 Maintain Human T Cell Function Through STAT5 Signaling,co-author, PloS One, 2016.
  • “Myc acts via the PTEN tumor suppressor to elicit autoregulation and genome-wide gene repression by activation of the Ezh2 methyltransferase,” first author, Cancer Research, 2013.
  • “Myc post-transcriptionally induces Hif1 protein and target gene expression in normal and cancer cells,” co-author, Cancer Research, 2012.

Professional and Community Involvement

  • Member of the PTAB Bar Association
  • Member of the Boston Patent Law Association
  • Member of the South Asian Bar Association

Education & Credentials

Suffolk University Law School
JD, 2022
Dartmouth College
PhD, 2013
Cancer Biology
State University of New York at Buffalo
BS, 2005, summa cum laude
Major in Biochemistry, Minor in Biochemical Pharmacology

Admissions

Massachusetts

United States Patent and Trademark Office